XML 105 R91.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholders' Equity - Stock Options - Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Number of shares    
Outstanding at beginning of period (in shares) 933,051  
Granted (in shares) 122,539  
Exercised (in shares) (148,427)  
Canceled (in shares) (24,271)  
Outstanding at end of period (in shares) 882,892 933,051
Weighted-average exercise price    
Outstanding at beginning of period (in dollars per share) $ 29.41  
Granted (in dollars per share) 51.99  
Exercised (in dollars per share) 15.31  
Canceled (in dollars per share) 68.13  
Outstanding at end of period (in dollars per share) $ 33.85 $ 29.41
Additional disclosures    
Weighted average remaining contractual term 6 years 11 months 1 day 7 years 7 months 2 days
Aggregate intrinsic value $ 16,990 $ 36,679
Vested and Exercisable    
Vested and exercisable, number (in shares) 658,858  
Vested and exercisable, weighted average exercise price (in dollars per share) $ 26.33  
Vested and exercisable, weighted average remaining contractual term 6 years 5 months 23 days  
Vested and exercisable, aggregate intrinsic value $ 16,001